1、Realizing the value of AI in MedTech within Asia PacificKey considerations to help improve trust,access and adoption of AI in MedTechSeptember 20242 2024 Copyright owned by one or more of the KPMG International entities.KPMG International entities provide no services to clients.All rights reserved.C

2、ontents01Executive summary02Introduction03Overview of challenges for translating and realizing the value of AI in MedTech04Access considerations for AI in MedTech05Capability considerations for AI in MedTech06Trust considerations for AI in MedTech07Call-to-action08Acknowledgments09References03061617

3、30536972753 2024 Copyright owned by one or more of the KPMG International entities.KPMG International entities provide no services to clients.All rights reserved.More than 60 percent of the worlds population lives in Asia Pacific.1 The demand for personalized and efficient healthcare is on the rise

4、and the MedTech industry is booming.But at the same time,the region is faced with an aging population and a growing burden of disease,exacerbated by limited healthcare infrastructure and manpower.There is enormous potential for the greater use of artificial intelligence(AI)in MedTech in Asia Pacific

5、,a market which is projected to be worth US$250 million,and growing by 50 percent between 2020 and 2028.6 As both public and private sectors increase their investments in healthcare,how can the region become a world leader in AI and MedTech?Executive summary 1 in 4 people in Asia Pacific will be age

6、d 60+by 20302 Rapidly aging populationAcross all age groups in Asia Pacific,700 million people lack the most basic healthcare support3 Limited access to healthcareChronic disease prevalence and disease-related complications are costing governments in Asia Pacific US$250 billion per year4Growing burd